» Articles » PMID: 31330821

Sphingolipid-Transporting Proteins As Cancer Therapeutic Targets

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jul 24
PMID 31330821
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The understanding of the role of sphingolipid metabolism in cancer has tremendously increased in the past ten years. Many tumors are characterized by imbalances in sphingolipid metabolism. In many cases, disorders of sphingolipid metabolism are also likely to cause or at least promote cancer. In this review, sphingolipid transport proteins and the processes catalyzed by them are regarded as essential components of sphingolipid metabolism. There is much to suggest that these processes are often rate-limiting steps for metabolism of individual sphingolipid species and thus represent potential target structures for pharmaceutical anticancer research. Here, we summarize empirical and biochemical data on different proteins with key roles in sphingolipid transport and their potential role in cancer.

Citing Articles

Sorting of complex sphingolipids within the cellular endomembrane systems.

Svistunov V, Ehrmann K, Lencer W, Schmieder S Front Cell Dev Biol. 2025; 12:1490870.

PMID: 40078962 PMC: 11897003. DOI: 10.3389/fcell.2024.1490870.


Dynamic metabolic modeling of ATP allocation during viral infection.

Lu A, Dukovski I, Segre D bioRxiv. 2024; .

PMID: 39605584 PMC: 11601281. DOI: 10.1101/2024.11.12.623198.


Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing.

Zhou S, Sun L, Mao F, Chen J Aging (Albany NY). 2024; 16(9):8031-8043.

PMID: 38713159 PMC: 11131980. DOI: 10.18632/aging.205803.


The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target.

Sami Alkafaas S, Elsalahaty M, Ismail D, Ali Radwan M, Samy ElKafas S, Loutfy S Cancer Cell Int. 2024; 24(1):89.

PMID: 38419070 PMC: 10903003. DOI: 10.1186/s12935-024-03221-8.


Ceramide-1-phosphate transfer protein enhances lipid transport by disrupting hydrophobic lipid-membrane contacts.

Rogers J, Geissler P PLoS Comput Biol. 2023; 19(4):e1010992.

PMID: 37036851 PMC: 10085062. DOI: 10.1371/journal.pcbi.1010992.


References
1.
Raya A, Revert F, Navarro S, Saus J . Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen. J Biol Chem. 1999; 274(18):12642-9. DOI: 10.1074/jbc.274.18.12642. View

2.
Yasuda S, Kitagawa H, Ueno M, Ishitani H, Fukasawa M, Nishijima M . A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J Biol Chem. 2001; 276(47):43994-4002. DOI: 10.1074/jbc.M104884200. View

3.
Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M . Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003; 426(6968):803-9. DOI: 10.1038/nature02188. View

4.
Fullekrug J, Simons K . Lipid rafts and apical membrane traffic. Ann N Y Acad Sci. 2004; 1014:164-9. DOI: 10.1196/annals.1294.017. View

5.
Malinina L, Malakhova M, Teplov A, Brown R, Patel D . Structural basis for glycosphingolipid transfer specificity. Nature. 2004; 430(7003):1048-53. PMC: 2640488. DOI: 10.1038/nature02856. View